Monday, May 1, 1995
BTGC becomes an earnings story
Bio-Technology General Corp. said it has turned the corner to profitability. The
company reported its first profitable operating period, for the quarter ended March 31,
with product sales of $5.2 million and net income of $402,000 ($0.01).
"The critical thing," said William Pursley, newly appointed senior vice
president of marketing, sales and commercial development, "is that the company isn't
planning any future financings, so there won't be any more dilution in the stock. The
company will be earnings-driven from now on."